vs
DigitalOcean Holdings, Inc.（DOCN）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是DigitalOcean Holdings, Inc.的1.2倍（$295.9M vs $242.4M），Bio-Techne净利率更高（12.8% vs 10.6%，领先2.3%），DigitalOcean Holdings, Inc.同比增速更快（18.3% vs -6.4%），过去两年DigitalOcean Holdings, Inc.的营收复合增速更高（14.5% vs 4.2%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
DOCN vs TECH — 直观对比
营收规模更大
TECH
是对方的1.2倍
$242.4M
营收增速更快
DOCN
高出24.7%
-6.4%
净利率更高
TECH
高出2.3%
10.6%
两年增速更快
DOCN
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $295.9M |
| 净利润 | $25.7M | $38.0M |
| 毛利率 | 58.7% | 64.6% |
| 营业利润率 | 16.0% | 18.4% |
| 净利率 | 10.6% | 12.8% |
| 营收同比 | 18.3% | -6.4% |
| 净利润同比 | 40.5% | 68.3% |
| 每股收益（稀释后） | $0.23 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCNTECH
| Q4 25 | $242.4M | $295.9M | ||
| Q3 25 | $229.6M | — | ||
| Q2 25 | $218.7M | $317.0M | ||
| Q1 25 | $210.7M | $316.2M | ||
| Q4 24 | $204.9M | $297.0M | ||
| Q3 24 | $198.5M | $289.5M | ||
| Q2 24 | $192.5M | $306.1M | ||
| Q1 24 | $184.7M | $303.4M |
净利润DOCNTECH
| Q4 25 | $25.7M | $38.0M | ||
| Q3 25 | $158.4M | — | ||
| Q2 25 | $37.0M | $-17.7M | ||
| Q1 25 | $38.2M | $22.6M | ||
| Q4 24 | $18.3M | $34.9M | ||
| Q3 24 | $32.9M | $33.6M | ||
| Q2 24 | $19.1M | $40.6M | ||
| Q1 24 | $14.1M | $49.1M |
毛利率DOCNTECH
| Q4 25 | 58.7% | 64.6% | ||
| Q3 25 | 59.6% | — | ||
| Q2 25 | 59.9% | 62.7% | ||
| Q1 25 | 61.4% | 67.9% | ||
| Q4 24 | 57.1% | 65.3% | ||
| Q3 24 | 60.2% | 63.2% | ||
| Q2 24 | 61.0% | 66.4% | ||
| Q1 24 | 60.7% | 67.4% |
营业利润率DOCNTECH
| Q4 25 | 16.0% | 18.4% | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | 16.3% | -7.5% | ||
| Q1 25 | 17.9% | 12.2% | ||
| Q4 24 | 15.9% | 16.0% | ||
| Q3 24 | 12.4% | 13.8% | ||
| Q2 24 | 11.6% | 15.0% | ||
| Q1 24 | 6.2% | 22.1% |
净利率DOCNTECH
| Q4 25 | 10.6% | 12.8% | ||
| Q3 25 | 69.0% | — | ||
| Q2 25 | 16.9% | -5.6% | ||
| Q1 25 | 18.1% | 7.1% | ||
| Q4 24 | 8.9% | 11.7% | ||
| Q3 24 | 16.6% | 11.6% | ||
| Q2 24 | 9.9% | 13.3% | ||
| Q1 24 | 7.7% | 16.2% |
每股收益（稀释后）DOCNTECH
| Q4 25 | $0.23 | $0.24 | ||
| Q3 25 | $1.51 | — | ||
| Q2 25 | $0.39 | $-0.11 | ||
| Q1 25 | $0.39 | $0.14 | ||
| Q4 24 | $0.21 | $0.22 | ||
| Q3 24 | $0.33 | $0.21 | ||
| Q2 24 | $0.20 | $0.26 | ||
| Q1 24 | $0.15 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $172.9M |
| 总债务越低越好 | $1.3B | $260.0M |
| 股东权益账面价值 | $-28.7M | $2.0B |
| 总资产 | $1.8B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DOCNTECH
| Q4 25 | $254.5M | $172.9M | ||
| Q3 25 | $236.6M | — | ||
| Q2 25 | $387.7M | $162.2M | ||
| Q1 25 | $360.4M | $140.7M | ||
| Q4 24 | $428.4M | $177.5M | ||
| Q3 24 | $439.9M | $187.5M | ||
| Q2 24 | $443.1M | $152.9M | ||
| Q1 24 | $419.1M | $145.3M |
总债务DOCNTECH
| Q4 25 | $1.3B | $260.0M | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $1.5B | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
股东权益DOCNTECH
| Q4 25 | $-28.7M | $2.0B | ||
| Q3 25 | $-69.6M | — | ||
| Q2 25 | $-175.2M | $1.9B | ||
| Q1 25 | $-210.7M | $2.0B | ||
| Q4 24 | $-203.0M | $2.1B | ||
| Q3 24 | $-211.7M | $2.1B | ||
| Q2 24 | $-253.8M | $2.1B | ||
| Q1 24 | $-286.1M | $2.0B |
总资产DOCNTECH
| Q4 25 | $1.8B | $2.5B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.5B | $2.7B | ||
| Q2 24 | $1.5B | $2.7B | ||
| Q1 24 | $1.5B | $2.7B |
负债/权益比DOCNTECH
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | — |
| 自由现金流经营现金流 - 资本支出 | $31.1M | — |
| 自由现金流率自由现金流/营收 | 12.8% | — |
| 资本支出强度资本支出/营收 | 10.8% | — |
| 现金转化率经营现金流/净利润 | 2.23× | — |
| 过去12个月自由现金流最近4个季度 | $180.5M | — |
8季度趋势，按日历期对齐
经营现金流DOCNTECH
| Q4 25 | $57.3M | — | ||
| Q3 25 | $95.8M | — | ||
| Q2 25 | $92.4M | $98.2M | ||
| Q1 25 | $64.1M | $41.1M | ||
| Q4 24 | $71.3M | $84.3M | ||
| Q3 24 | $73.4M | $63.9M | ||
| Q2 24 | $71.3M | $75.5M | ||
| Q1 24 | $66.7M | $81.0M |
自由现金流DOCNTECH
| Q4 25 | $31.1M | — | ||
| Q3 25 | $88.0M | — | ||
| Q2 25 | $59.3M | $93.3M | ||
| Q1 25 | $2.1M | $31.0M | ||
| Q4 24 | $26.1M | $77.5M | ||
| Q3 24 | $16.0M | $54.7M | ||
| Q2 24 | $39.5M | $57.5M | ||
| Q1 24 | $23.0M | $64.5M |
自由现金流率DOCNTECH
| Q4 25 | 12.8% | — | ||
| Q3 25 | 38.3% | — | ||
| Q2 25 | 27.1% | 29.4% | ||
| Q1 25 | 1.0% | 9.8% | ||
| Q4 24 | 12.7% | 26.1% | ||
| Q3 24 | 8.1% | 18.9% | ||
| Q2 24 | 20.5% | 18.8% | ||
| Q1 24 | 12.5% | 21.3% |
资本支出强度DOCNTECH
| Q4 25 | 10.8% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 15.2% | 1.5% | ||
| Q1 25 | 29.4% | 3.2% | ||
| Q4 24 | 22.1% | 2.3% | ||
| Q3 24 | 28.9% | 3.2% | ||
| Q2 24 | 16.6% | 5.9% | ||
| Q1 24 | 23.6% | 5.4% |
现金转化率DOCNTECH
| Q4 25 | 2.23× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 1.68× | 1.82× | ||
| Q4 24 | 3.91× | 2.42× | ||
| Q3 24 | 2.23× | 1.90× | ||
| Q2 24 | 3.73× | 1.86× | ||
| Q1 24 | 4.72× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
